LFMD: financial statements from SEC — TradeAlmanac

LFMD

LifeMD, Inc.: financial statements

Company reports as filed with the U.S. Securities and Exchange Commission.

AnnualQuarterly

Income statement

Metric	Mar 31, 2026	Sep 30, 2025	Jun 30, 2025	Mar 31, 2025	Sep 30, 2024	Jun 30, 2024
Revenue	50m	60m	63m	64m	53m	51m
Cost of revenue	6m	7m	7m	9m	5m	5m
Gross profit	44m	53m	55m	55m	48m	46m
Selling, general and administrative	15m	17m	18m	17m	18m	19m
Operating expenses	53m	55m	56m	55m	52m	52m
Operating income	−9m	−2m	−451,562	974,342	−4m	−6m
Interest expense	−56,476	262,456	663,027	626,275	558,597	531,468
Pre-tax income	−9m	−3m	—	−2m	−5m	—
Income tax	—	169,134	—	—	232,523	—
Net income	−9m	−4m	−2m	−183,778	−5m	−8m
Earnings per share	−0.20	−0.10	−0.06	0.01	−0.13	−0.19
Earnings per share, diluted	−0.20	−0.10	−0.06	0.01	−0.13	−0.19
Weighted average shares	47m	46m	44m	43m	42m	41m
Weighted average shares, diluted	47m	46m	44m	46m	42m	41m

Balance sheet

Metric	Mar 31, 2026	Dec 31, 2025	Sep 30, 2025	Jun 30, 2025	Mar 31, 2025	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024
Cash and equivalents	34m	—	—	36m	34m	35m	38m	36m
Receivables	10m	9m

Cash flow

Metric	Mar 31, 2026	Mar 31, 2025
Operating cash flow	444,624	3m
Depreciation and amortisation	289,458	162,566
Share-based compensation	1m	3m
Capital expenditure	105,178	122,211
Investing cash flow	−2m	−3m
Dividends paid	776,563

Amounts in USD unless stated otherwise. Sources: Nasdaq Trader, Yahoo Finance, U.S. Securities and Exchange Commission (EDGAR)